Zobrazeno 1 - 10
of 212
pro vyhledávání: '"R Paul Robertson"'
Autor:
Piotr Witkowski, Louis H. Philipson, John B. Buse, R. Paul Robertson, Rodolfo Alejandro, Melena D. Bellin, Fouad Kandeel, David Baidal, Jason L. Gaglia, Andrew M. Posselt, Roi Anteby, Piotr J. Bachul, Yaser Al-Salmay, Kumar Jayant, Angelica Perez-Gutierrez, Rolf N. Barth, John J. Fung, Camillo Ricordi
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
Clinical islet allotransplantation has been successfully regulated as tissue/organ for transplantation in number of countries and is recognized as a safe and efficacious therapy for selected patients with type 1 diabetes mellitus. However, in the Uni
Externí odkaz:
https://doaj.org/article/8ce3c7aabdf24c8ebc54e4691f1ff99f
Autor:
R. Paul Robertson
Publikováno v:
OBM Transplantation. :1-12
Pancreatic islet transplantation (ITx) has moved from the experimental phase of development to a position of an accepted and appropriate procedure to apply in clinical medicine. The primary indication for use of ITx is for management of dangerous and
Autor:
Sudha S. Shankar, Douglas S. Lee, Ralph H. Raymond, Roberto A. Calle, Claudio Cobelli, Atalanta Ghosh, R. Paul Robertson, Hartmut Ruetten, Myrlene A. Staten, Darko Stefanovski, Adrian Vella, Sanya Whitaker, David A. Fryburg
Publikováno v:
Contemporary Clinical Trials Communications, Vol 10, Iss , Pp 94-99 (2018)
Standard practice to minimize variability in beta cell function (BCF) measurement is to test in inpatient (IP) settings. IP testing strains trial subjects, investigators, and budgets. Outpatient (OP) testing may be a solution although there are few r
Externí odkaz:
https://doaj.org/article/93654348a84b46b193cff126cf88a764
Autor:
R Paul Robertson
Publikováno v:
Journal of Endocrinology.
Glucagon is a peptide hormone that is produced primarily by the alpha cells in the islet of Langerhans in the pancreas, but also in intestinal enteroendocrine cells and in some neurons. Approximately 100 years ago several research groups discovered t
Publikováno v:
Journal of the Endocrine Society. 7
Context Chronic exposure of pancreatic islets to elevated glucose levels causes progressive declines in beta cell Pdx-1 and insulin gene expression, and glucose-induced insulin secretion. This has been shown to be associated with excessive islet reac
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
Autor:
Rolf N. Barth, Mark A. Hardy, Dixon B. Kaufman, Raghavendra G. Mirmira, Piotr Witkowski, David A. Baidal, Raja Kandaswamy, Louis H. Philipson, Chirag S. Desai, Melena D. Bellin, Piotr J. Bachul, Jason L. Gaglia, John J. Fung, Michelle A. Josephson, Oyedolamu K. Olaitan, Jonathan A. Fridell, John B. Buse, Peter G. Stock, Jason R. Wellen, Peter L. Abrams, Robert C. Harland, Bashoo Naziruddin, Jordan Pyda, Amittha Wickrema, Camillo Ricordi, Marwan S Abouljoud, Lloyd E. Ratner, Silke V. Niederhaus, Tomasz Kozlowski, Michael Charlton, Kumar Jayant, David C. Mulligan, R. Paul Robertson, James F. Markmann, Rachael C. Forbes, Robert J. Stratta, J. Michael Millis, Anthony J. Japour, Jon S. Odorico, Marlon F. Levy, Rodolfo Alejandro, Fouad Kandeel, Appakalai N. Balamurugan, Kenneth A. Andreoni, Yolanda T. Becker
Publikováno v:
Am J Transplant
Islet allotransplantation in the United States (US) is facing an imminent demise. Despite nearly three decades of progress in the field, an archaic regulatory framework has stymied US clinical practice. Current regulations do not reflect the state-of
Autor:
R. Paul Robertson
Publikováno v:
International Journal of Molecular Sciences. 24:3082
This perspective examines the proposition that chronically elevated blood glucose levels caused by type 2 diabetes (T2D) harm body tissues by locally generating reactive oxygen species (ROS). A feed-forward scenario is described in which the initial
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Paul Robertson
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 104:6275-6278
Autor:
Kenneth A. Andreoni, Beth Schrope, Robert C. Harland, R. Paul Robertson, John B. Buse, Ling-Jia Wang, Jordan Pyda, Oyedolamu K. Olaitan, Yolanda T. Becker, Mark A. Hardy, Roi Anteby, Gregory L. Szot, Piotr Witkowski, Piotr J. Bachul, Chirag S. Desai, Jon S. Odorico, Silke V. Niederhaus, Martin Wijkstrom, Fouad Kandeel, Raja Kandaswamy, Michelle A. Josephson, Tomasz Kozlowski, Peter L. Abrams, Jason L. Gaglia, Joseph R. Leventhal, Wanxing Cui, Shakir Hussein, Camillo Ricordi, Andrew M. Posselt, Robert J. Stratta
Publikováno v:
Journal of clinical medicine, vol 10, iss 13
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 2878, p 2878 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 2878, p 2878 (2021)
The Food and Drug Administration (FDA) has been regulating human islets for allotransplantation as a biologic drug in the US. Consequently, the requirement of a biological license application (BLA) approval before clinical use of islet transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::649fe399a90d397c08b684c080c26a6a
https://escholarship.org/uc/item/1236c9p6
https://escholarship.org/uc/item/1236c9p6